Table 1.
Patients’ Characteristics
| Characteristics | Value | Characteristics | Value |
|---|---|---|---|
| Age (years) | CT | 58 (12.30%) | |
| ≤60 | 355 (75.69%) | MRI | 397 (84.60%) |
| >60 | 114 (24.31%) | PET/CT | 14 (2.90%) |
| Hemoglobin | Parametrial invasion | ||
| ≥120g/L | 345 (73.56%) | No | 40 (8.53%) |
| <120g/L | 124 (26.44%) | Parametrial extension | 235 (50.11%) |
| White blood cell counts | Pelvic wall involvement | 194 (41.36%) | |
| <10*10E91/L | 371 (79.10%) | FIGO | |
| ≥10*10E91/L | II | 167 (35.61%) | |
| SCC | 98 (20.90%) | III | 302 (64.39%) |
| ≤2ng/mL | 111 (23.67%) | Chemotherapy | |
| >2ng/mL | No | 78 (16.63%) | |
| Tumor length | 358 (76.33%) | Yes | 391 (83.37%) |
| ≤5.1cm | 283 (60.34%) | Radiotherapy | |
| >5.1cm | 186 (39.66%) | Conventional | 270 (57.57%) |
| Tumor width | IMRT | 199 (42.43%) | |
| ≤4.13cm | 362 (77.19%) | Time of Radiotherapy | |
| >4.13cm | 107 (22.81%) | ≤56days | 172 (36.67%) |
| LTI | >56days | 297 (63.33%) | |
| No | 330 (70.36%) | Glycididazole Sodium | |
| Yes | 139 (29.64%) | No | 411 (87.63%) |
| LN metastasis | Yes | 58 (12.37%) | |
| No | 277 (59.06%) | Thermotherapy | |
| Yes | 192 (40.94%) | No | 346 (73.77%) |
| Imaging | Yes | 123 (26.23%) |